Please use this identifier to cite or link to this item: https://doi.org/10.1183/09031936.00084808
DC FieldValue
dc.titleSuberoylanilide hydroxamic acid: A potential epigenetic therapeutic agent for lung fibrosis?
dc.contributor.authorWang, Z.
dc.contributor.authorChen, C.
dc.contributor.authorLareu, R.R.
dc.contributor.authorRaghunath, M.
dc.contributor.authorFinger, S.N.
dc.contributor.authorDo, Kwajah MM S.
dc.contributor.authorSchwarz, H.
dc.contributor.authorJung, M.
dc.contributor.authorSwanson, N.
dc.date.accessioned2011-08-01T03:05:55Z
dc.date.available2011-08-01T03:05:55Z
dc.date.issued2009
dc.identifier.citationWang, Z., Chen, C., Lareu, R.R., Raghunath, M., Finger, S.N., Do, Kwajah MM S., Schwarz, H., Jung, M., Swanson, N. (2009). Suberoylanilide hydroxamic acid: A potential epigenetic therapeutic agent for lung fibrosis?. European Respiratory Journal 34 (1) : 145-155. ScholarBank@NUS Repository. https://doi.org/10.1183/09031936.00084808
dc.identifier.issn09031936
dc.identifier.issn13993003
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/25157
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1183/09031936.00084808
dc.sourceScopus
dc.subjectAntifibrotic
dc.subjectCollagen
dc.subjectFibroblast
dc.subjectHistone deacetylase inhibitor
dc.subjectPulmonary fibrosis
dc.subjectSuberoylanilide hydroxamic acid
dc.typeArticle
dc.contributor.departmentPHYSIOLOGY
dc.contributor.departmentDIVISION OF BIOENGINEERING
dc.description.doi10.1183/09031936.00084808
dc.description.sourcetitleEuropean Respiratory Journal
dc.description.volume34
dc.description.issue1
dc.description.page145-155
dc.identifier.isiut000267777000021
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

68
checked on Aug 10, 2022

WEB OF SCIENCETM
Citations

67
checked on Aug 10, 2022

Page view(s)

283
checked on Aug 4, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.